DK1841458T3 - Behandlingsregime med overfladeaktivt stof til behandling eller forebyggelse af bronkopulmonal dysplasi - Google Patents

Behandlingsregime med overfladeaktivt stof til behandling eller forebyggelse af bronkopulmonal dysplasi

Info

Publication number
DK1841458T3
DK1841458T3 DK06717499.5T DK06717499T DK1841458T3 DK 1841458 T3 DK1841458 T3 DK 1841458T3 DK 06717499 T DK06717499 T DK 06717499T DK 1841458 T3 DK1841458 T3 DK 1841458T3
Authority
DK
Denmark
Prior art keywords
treat
bronchopulmonary dysplasia
treatment regimen
surfactant treatment
prevent
Prior art date
Application number
DK06717499.5T
Other languages
English (en)
Inventor
Anthony Killian
Robert Segal
Carlos Guardia
Christopher Schaber
Original Assignee
Discovery Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36169079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1841458(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Discovery Lab Inc filed Critical Discovery Lab Inc
Application granted granted Critical
Publication of DK1841458T3 publication Critical patent/DK1841458T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
DK06717499.5T 2005-01-06 2006-01-06 Behandlingsregime med overfladeaktivt stof til behandling eller forebyggelse af bronkopulmonal dysplasi DK1841458T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64180505P 2005-01-06 2005-01-06
PCT/US2006/000308 WO2006074296A1 (en) 2005-01-06 2006-01-06 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Publications (1)

Publication Number Publication Date
DK1841458T3 true DK1841458T3 (da) 2012-04-23

Family

ID=36169079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06717499.5T DK1841458T3 (da) 2005-01-06 2006-01-06 Behandlingsregime med overfladeaktivt stof til behandling eller forebyggelse af bronkopulmonal dysplasi

Country Status (14)

Country Link
US (1) US7541331B2 (da)
EP (2) EP2298349A1 (da)
JP (2) JP2008526868A (da)
AT (1) ATE538814T1 (da)
AU (1) AU2006203978B2 (da)
CA (1) CA2593758A1 (da)
CY (1) CY1112769T1 (da)
DK (1) DK1841458T3 (da)
ES (1) ES2380046T3 (da)
HK (1) HK1109078A1 (da)
PL (1) PL1841458T3 (da)
PT (1) PT1841458E (da)
SI (1) SI1841458T1 (da)
WO (1) WO2006074296A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
KR20090060348A (ko) * 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US7951781B2 (en) * 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
AU2009212693B2 (en) 2008-01-31 2014-05-01 Vanderbilt University Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
KR20170005155A (ko) * 2008-01-31 2017-01-11 반더빌트유니버시티 폐의 용태에 따른 치료 방법
AU2014204490B2 (en) * 2008-01-31 2016-05-12 Vanderbilt University Therapeutic treatment for lung condtions
WO2011116188A1 (en) * 2010-03-19 2011-09-22 Wisconsin Alumni Research Foundation Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
US20190175502A1 (en) * 2015-10-20 2019-06-13 Indiana University Research & Technology Corporation Methods and compositions for treating lung disease of prematurity
RU2757902C2 (ru) * 2016-12-22 2021-10-22 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Терапевтическая комбинация для лечения развивающейся bpd, содержащая легочный сурфактант и стероид
CN112423733A (zh) * 2018-04-23 2021-02-26 奇斯药制品公司 用于预防bpd的包含肺表面活性物质和类固醇的治疗组合
KR102173673B1 (ko) * 2018-05-04 2020-11-03 사회복지법인 삼성생명공익재단 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법
US20230097886A1 (en) * 2021-07-30 2023-03-30 Ayuvis Research, Inc. Compositions and methods for the treatment of bronchopulmonary dysplasia (bpd) and bpd-associated pulmonary hypertension

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US502495A (en) 1893-08-01 klijsel
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4918161A (en) 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
IT1203873B (it) 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
ATE163013T1 (de) 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US6013619A (en) 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US4861756A (en) 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5238920A (en) 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
US5272252A (en) 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
WO1993021221A1 (en) 1992-04-10 1993-10-28 Abbott Laboratories Pulmonary surfactant protein fragments
US5302481A (en) 1993-06-07 1994-04-12 Xerox Corporation Toner compositions with negative charge enhancing complexes
KR100342806B1 (ko) 1993-12-08 2002-11-29 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 신규합성펩티드,이를함유하는폐표면활성제및호흡장애증후군치료제
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5863563A (en) * 1994-10-20 1999-01-26 Alphagene Inc. Treatment of pulmonary conditions associated with insufficient secretion of surfactant
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
JP2004305006A (ja) * 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
AU2005247410A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
AU2005280281A1 (en) * 2004-08-27 2006-03-09 Discovery Laboratories, Inc. Methods, systems and devices for noninvasive pulmonary delivery

Also Published As

Publication number Publication date
SI1841458T1 (sl) 2012-04-30
EP1841458A1 (en) 2007-10-10
EP1841458B1 (en) 2011-12-28
PT1841458E (pt) 2012-04-10
AU2006203978B2 (en) 2011-11-03
ES2380046T3 (es) 2012-05-08
EP2298349A1 (en) 2011-03-23
HK1109078A1 (en) 2008-05-30
PL1841458T3 (pl) 2012-05-31
WO2006074296A1 (en) 2006-07-13
CY1112769T1 (el) 2016-02-10
US20060194728A1 (en) 2006-08-31
JP2008526868A (ja) 2008-07-24
JP2013177422A (ja) 2013-09-09
EP1841458B9 (en) 2012-12-12
ATE538814T1 (de) 2012-01-15
CA2593758A1 (en) 2006-07-13
US7541331B2 (en) 2009-06-02
AU2006203978A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
DK1841458T3 (da) Behandlingsregime med overfladeaktivt stof til behandling eller forebyggelse af bronkopulmonal dysplasi
CY1122292T1 (el) Ενωσεις και μεθοδοι για αντιϊικη αγωγη
CY1123821T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια της δυσλειτουργιας του μεϊβομιανου αδενα
DK1830843T3 (da) Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
BRPI0606524A2 (pt) derivados de indol para o tratamento de infecções virais
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
EA201492205A1 (ru) Макроциклические ингибиторы вирусов flaviviridae
DK2918288T3 (da) Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi
CL2013003360A1 (es) “compuestos derivados de 4-aril-n-[3-(sulfonimidoil)fenil]-1,3,5-triazin-2-amina sustituidos, inhibidores cdk; compuestos intermediarios, composición y combinación farmacéutica que los comprende; y su uso en el tratamiento de enfermedades hiperproliferativas, infecciosas inducidas por virus y/o cardiovasculares”. pct
EA201492209A1 (ru) Макроциклические ингибиторы вирусов flaviviridae
DK1708991T3 (da) Sulfonamid derivater til behandling af sygdomme
WO2014169280A3 (en) Deuterated nucleoside prodrugs useful for treating hcv
EA200901241A1 (ru) Соединения для лечения гепатита с
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
EA201290053A1 (ru) Ингибиторы вирусов flaviviridae
EA200970805A1 (ru) Ингибиторы серинпротеаз для лечения hcv инфекций
BR112014030639A2 (pt) inibidores macrocíclicos de vírus flaviviridae
DK3068393T5 (da) Kombinationsterapi som inkluderer en mdm2-inhibitor og et eller flere yderligere farmaceutisk aktive midler til behandlingen af kræftformer
NO20074613L (no) Tricykliske nukleosidforbindelser for behandling av virale infeksjoner
DK1520175T3 (da) Oncolytiske vira som midler til fænotypebestemmelse af neoplasmer
DE602007008874D1 (de) Hemmer der neubildung menschlicher immundefekt-viren
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
NO20062146L (no) Nukleosidforbindelser for behandling av virusinfeksjoner
DK1833799T3 (da) 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil